EGFR was also shown to be positive in over 80% of exosomes from NSCLC patients, while less than 2% of chronic lung inflammation was discovered to be EGFR positive; this suggests that EFGR could serve as an indicator to distinguish between NSCLC and chronic lung inflammation [59]. Here, EGFR is linked to non-small cell lung carcinoma.